{
 "metadata": {
  "name": "",
  "signature": "sha256:a93b071174d8593d53df7746475cb2d04be6e5dd093898deb7cf0f1a27a65bb5"
 },
 "nbformat": 3,
 "nbformat_minor": 0,
 "worksheets": [
  {
   "cells": [
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "Analysis of Job 710587"
     ]
    },
    {
     "cell_type": "markdown",
     "metadata": {},
     "source": [
      "2015-04-04 Toby"
     ]
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import pandas as pd\n",
      "import matplotlib.pyplot as plt\n",
      "\n",
      "%matplotlib inline\n",
      "%pylab inline"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Populating the interactive namespace from numpy and matplotlib\n"
       ]
      }
     ],
     "prompt_number": 1
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "import sys\n",
      "sys.path.append(\"/home/toby/crowdsourcing/drug_disease_semantics/src/\")\n",
      "\n",
      "from filter_data import filter_data\n",
      "from true_relation_type import get_euadr_relation_type\n",
      "from broad_reltype_performance import determine_broad_reltype_results\n",
      "\n",
      "from broad_reltype_summary import broad_reltype_summary\n",
      "from get_orig_problem import get_orig_problem\n",
      "\n",
      "from collections import defaultdict"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 2
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "settings = {\n",
      "    \"loc\": \"/home/toby/crowdsourcing/drug_disease_semantics/data\",\n",
      "    \"fname\": \"job_710587_full_with_untrusted.tsv\",\n",
      "    \"data_subset\": \"normal\",\n",
      "    \"min_accuracy\": 0.7,\n",
      "    \"max_accuracy\": 1.0,\n",
      "    \"sentence_type\": \"all\"\n",
      "}\n",
      "\n",
      "broad_reltype_summary(settings)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Distribution of matches with gold standard based on response rank:\n",
        "0    44\n",
        "1     5\n",
        "2     4\n",
        "3     0\n",
        "dtype: float64\n",
        "\n",
        "Total number of work units for this subset of data: 61\n",
        "\n",
        "Number of correct responses with respect to the rank of confidence score:\n",
        "44.0/61 (72.131147541%) work units had the correct answer in the top ranked position\n"
       ]
      },
      {
       "metadata": {},
       "output_type": "display_data",
       "png": "iVBORw0KGgoAAAANSUhEUgAAAYcAAAExCAYAAACXjW4WAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nTkSuQmCC\n",
       "text": [
        "<matplotlib.figure.Figure at 0x7f2f46a42ed0>"
       ]
      }
     ],
     "prompt_number": 3
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "data.columns.values"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "metadata": {},
       "output_type": "pyout",
       "prompt_number": 17,
       "text": [
        "array(['_unit_id', '_created_at', '_golden', '_id', '_missed',\n",
        "       '_started_at', '_tainted', '_channel', '_trust', '_worker_id',\n",
        "       '_country', '_region', '_city', '_ip', 'broad_rel_type',\n",
        "       'comments_box', 'deep_semantics', 'broad_rel_type_gold',\n",
        "       'data_subset', 'deep_semantics_gold', 'form_object', 'form_subject',\n",
        "       'formatted_sentence', 'gold_std_association_type', 'num_sentence',\n",
        "       'object_end', 'object_start', 'object_text', 'object_type',\n",
        "       'original_sentence', 'pubmed_id', 'subject_end', 'subject_start',\n",
        "       'subject_text', 'subject_type'], dtype=object)"
       ]
      }
     ],
     "prompt_number": 17
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "settings = {\n",
      "    \"loc\": \"/home/toby/crowdsourcing/drug_disease_semantics/data\",\n",
      "    \"fname\": \"job_710587_full_with_untrusted.tsv\",\n",
      "    \"data_subset\": \"normal\",\n",
      "    \"min_accuracy\": 0.7,\n",
      "    \"max_accuracy\": 1.0,\n",
      "    \"sentence_type\": \"all\"\n",
      "}\n",
      "\n",
      "data = filter_data(settings)\n",
      "euadr_relation_type = get_euadr_relation_type()\n",
      "results = determine_broad_reltype_results(euadr_relation_type, data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 4
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "orig_problems = get_orig_problem(data)"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [],
     "prompt_number": 5
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "errors = defaultdict(set)\n",
      "euadr = defaultdict(int)\n",
      "for unit_id, group in results.groupby(\"unit_id\"):\n",
      "    if group[\"match\"].iloc[0] != 1:\n",
      "        errors[group[\"broad_rel_type\"].iloc[0]].add(unit_id)\n",
      "        \n",
      "        euadr[euadr_relation_type[unit_id]] += 1\n",
      "        \n",
      "\n",
      "for key, val in errors.items():\n",
      "    print key\n",
      "    print val\n",
      "    print len(val)\n",
      "    print\n",
      "    \n",
      "    \n",
      "print euadr"
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "positive\n",
        "set([698758017, 698758020, 698757991, 698758027, 698758008, 698757970, 698757976, 698757977, 698758010, 698758011])\n",
        "10\n",
        "\n",
        "speculative\n",
        "set([698757984, 698758026, 698758028, 698757989])\n",
        "4\n",
        "\n",
        "false\n",
        "set([698758014])\n",
        "1\n",
        "\n",
        "negative\n",
        "set([698757972, 698758006])\n",
        "2\n",
        "\n",
        "defaultdict(<type 'int'>, {'positive': 3, 'speculative': 1, 'false': 13})\n"
       ]
      }
     ],
     "prompt_number": 13
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "for rel_type, unit_ids in errors.items():\n",
      "    print \"Crowd chosen relation type:\", rel_type\n",
      "    print \"Number of errors:\", len(unit_ids)\n",
      "    \n",
      "    for unit_id in unit_ids:\n",
      "        print \"Unit id:\", unit_id\n",
      "        subset = results.query(\"unit_id == {0}\".format(unit_id))\n",
      "        print subset\n",
      "        print\n",
      "        print orig_problems[unit_id][3]\n",
      "        print\n",
      "        print \"EU-ADR result:\", euadr_relation_type[unit_id]\n",
      "        print \"--------------------------------------------\"\n",
      "    \n",
      "    \n",
      "    "
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "Crowd chosen relation type: positive\n",
        "Number of errors: 10\n",
        "Unit id: 698758017\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758017       positive      6.9068          8            0.78473      0\n",
        "1  698758017    speculative      1.8947          2            0.21527      0\n",
        "\n",
        "Two years after initiating [[SRL]], she presented complaints of progressive dyspnoea, [[nonproductive cough]], chest pain and low-grade fever of 1 month duration.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758020\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758020       positive      4.5643          5           0.501296      0\n",
        "1  698758020    speculative      4.5407          5           0.498704      1\n",
        "\n",
        "At this time, [[posaconazole]] should probably be reserved for prophylaxis in patients at high risk for invasive fungal infection, as salvage therapy in refractory or [[resistant infections]], or for patients with intolerance to other therapies.\n",
        "\n",
        "EU-ADR result: speculative\n",
        "--------------------------------------------\n",
        "Unit id: 698757991\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757991       positive      4.5302          5           0.497551      0\n",
        "0  698757991          false      2.7248          3           0.299264      1\n",
        "1  698757991       negative      1.8500          2           0.203185      0\n",
        "\n",
        "Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral [[anticoagulant]] and instituting heparin therapy prior to the planned dental procedure, which can result in [[thromboembolism]] and increased morbidity and mortality.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758027\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758027       positive      5.9119          7           0.674728      0\n",
        "1  698758027    speculative      2.8500          3           0.325272      0\n",
        "\n",
        "Maternal use of [[BZD]] and/or HBRA may increase the risk for [[preterm birth]] and low birth weight and cause neonatal symptoms, but does not appear to have a strong teratogenic potential.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758008\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758008       positive      6.6679          8           0.799882      0\n",
        "0  698758008       negative      0.8500          1           0.101966      0\n",
        "2  698758008    speculative      0.8182          1           0.098151      0\n",
        "\n",
        "The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium ([[DSS]])-induced [[colitis-associated neoplasia]].\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698757970\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757970       positive      6.8960          8           0.808280      0\n",
        "0  698757970          false      0.8500          1           0.099628      1\n",
        "2  698757970    speculative      0.7857          1           0.092092      0\n",
        "\n",
        "[[Cardiovascular thromboembolic adverse effects]] associated with [[cyclooxygenase]]-2 selective inhibitors and nonselective antiinflammatory drugs.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698757976\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757976       positive      6.7906          8           0.795926      0\n",
        "2  698757976    speculative      0.9286          1           0.108841      0\n",
        "0  698757976          false      0.8125          1           0.095233      1\n",
        "\n",
        "Review of recent results of [[montelukast]] use as a monotherapy in children with [[mild asthma]].\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698757977\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757977       positive      6.9556          8           0.801281      0\n",
        "1  698757977    speculative      1.7250          2           0.198719      0\n",
        "\n",
        "This article reviewed recent results from randomized, double-blind studies of children with [[mild asthma]] treated with [[montelukast]], a leukotriene receptor antagonist that is approved for the treatment of asthma and allergic rhinitis in children and adults.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758010\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758010       positive      6.1282          7           0.696268      0\n",
        "1  698758010    speculative      2.6733          3           0.303732      0"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Recently, there have been reports of [[noninfectious granulomatous syndromes]] in patients receiving [[etanercept]] for a variety of diseases.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758011\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758011       positive       8.105          9            0.89017      0\n",
        "1  698758011    speculative       1.000          1            0.10983      0\n",
        "\n",
        "Past use of antimetabolites, T-cell inhibitors, [[alkylating agents]], and other immunosuppressives is ascertained from medical records of approximately 9,250 [[ocular inflammation]] patients at five tertiary centers over up to 30 years.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Crowd chosen relation type: speculative\n",
        "Number of errors: 4\n",
        "Unit id: 698757984\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757984    speculative      4.4782          5           0.519802      0\n",
        "1  698757984       positive      2.5013          3           0.290336      1\n",
        "0  698757984          false      1.6357          2           0.189862      0\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and [[indomethacin]] ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "EU-ADR result: positive\n",
        "--------------------------------------------\n",
        "Unit id: 698758026\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758026    speculative      4.5405          5            0.51821      0\n",
        "0  698758026       positive      4.2214          5            0.48179      0\n",
        "\n",
        "Exposure to [[Benzodiazepines]] (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, [[orofacial clefts]].\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758028\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758028    speculative      5.3191          6            0.60434      0\n",
        "0  698758028       positive      3.4824          4            0.39566      0\n",
        "\n",
        "Exposure to Benzodiazepines ([[BZD]]) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, [[orofacial clefts]].\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698757989\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757989    speculative      5.9840          7           0.683331      0\n",
        "1  698757989       positive      1.9231          2           0.219605      1\n",
        "0  698757989          false      0.8500          1           0.097064      0\n",
        "\n",
        "The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]] on [[glioma]] cell lines.\n",
        "\n",
        "EU-ADR result: positive\n",
        "--------------------------------------------\n",
        "Crowd chosen relation type: false\n",
        "Number of errors: 1\n",
        "Unit id: 698758014\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758014          false      4.2872          5           0.514293      0\n",
        "1  698758014       negative      2.3864          3           0.286273      0\n",
        "2  698758014       positive      0.8500          1           0.101966      1\n",
        "3  698758014    speculative      0.8125          1           0.097468      0\n",
        "\n",
        "Data of our study revealed an unexpected high rate of hypogonadism irrespective of [[cyclophosphamide]] use, and subclinical involvement of the testes by the [[vasculitis]] itself might be an alternative explanation.\n",
        "\n",
        "EU-ADR result: positive\n",
        "--------------------------------------------\n",
        "Crowd chosen relation type: negative\n",
        "Number of errors: 2\n",
        "Unit id: 698757972\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757972       negative      3.5375          4           0.403552      0\n",
        "2  698757972       positive      2.7802          3           0.317161      0\n",
        "0  698757972          false      1.6357          2           0.186598      1\n",
        "3  698757972    speculative      0.8125          1           0.092689      0\n",
        "\n",
        "No significant differences were observed between FeSO4+citrate and [[NaFe-EDTA]] fortification, regarding mitigation of [[iron-deficiency anemia]] (IDA) or regarding CRP, growth, infections, or side-effects.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n",
        "Unit id: 698758006\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758006       negative      4.3890          5           0.498665      0\n",
        "2  698758006       positive      3.5625          4           0.404761      0\n",
        "0  698758006          false      0.8500          1           0.096574      1\n",
        "\n",
        "Compared with both diuretics and contemporary agents, [[amlodipine]] decreases cardiovascular events to a similar or greater extent without evidence for increased [[coronary heart disease]], gastrointestinal bleeding or cancer.\n",
        "\n",
        "EU-ADR result: false\n",
        "--------------------------------------------\n"
       ]
      }
     ],
     "prompt_number": 11
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [
      "# lets see a summary for all work units:\n",
      "for unit_id, group in results.groupby(\"unit_id\"):\n",
      "    print \"unit id:\", unit_id\n",
      "    print group\n",
      "    print\n",
      "    print orig_problems[unit_id][3]\n",
      "    print\n",
      "    print \"------------------------------------------------------------\""
     ],
     "language": "python",
     "metadata": {},
     "outputs": [
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "unit id: 698757970\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757970       positive      6.8960          8           0.808280      0\n",
        "0  698757970          false      0.8500          1           0.099628      1\n",
        "2  698757970    speculative      0.7857          1           0.092092      0\n",
        "\n",
        "[[Cardiovascular thromboembolic adverse effects]] associated with [[cyclooxygenase]]-2 selective inhibitors and nonselective antiinflammatory drugs.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757972\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757972       negative      3.5375          4           0.403552      0\n",
        "2  698757972       positive      2.7802          3           0.317161      0\n",
        "0  698757972          false      1.6357          2           0.186598      1\n",
        "3  698757972    speculative      0.8125          1           0.092689      0\n",
        "\n",
        "No significant differences were observed between FeSO4+citrate and [[NaFe-EDTA]] fortification, regarding mitigation of [[iron-deficiency anemia]] (IDA) or regarding CRP, growth, infections, or side-effects.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757975\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757975          false      7.9534          9           0.907311      1\n",
        "1  698757975       positive      0.8125          1           0.092689      0\n",
        "\n",
        "Gingival samples were collected from eight normal healthy individuals, eight patients with [[periodontitis]], and eight patients with cyclosporin A ([[CsA]])-induced gingival overgrowth.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757976\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757976       positive      6.7906          8           0.795926      0\n",
        "2  698757976    speculative      0.9286          1           0.108841      0\n",
        "0  698757976          false      0.8125          1           0.095233      1\n",
        "\n",
        "Review of recent results of [[montelukast]] use as a monotherapy in children with [[mild asthma]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757977\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757977       positive      6.9556          8           0.801281      0\n",
        "1  698757977    speculative      1.7250          2           0.198719      0\n",
        "\n",
        "This article reviewed recent results from randomized, double-blind studies of children with [[mild asthma]] treated with [[montelukast]], a leukotriene receptor antagonist that is approved for the treatment of asthma and allergic rhinitis in children and adults.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757978\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757978       positive      6.0585          7           0.710116      1\n",
        "0  698757978          false      1.5982          2           0.187325      0\n",
        "2  698757978    speculative      0.8750          1           0.102559      0\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, [[cisplatin]], cytarabine and prednisone.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757979\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757979       positive      7.1161          8           0.812164      1\n",
        "2  698757979    speculative      0.8333          1           0.095105      0\n",
        "0  698757979          false      0.8125          1           0.092731      0\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and [[prednisone]] alternating with three courses of etoposide, cisplatin, cytarabine and [[prednisone]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757980\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757980       positive      5.2337          6           0.607496      1\n",
        "2  698757980    speculative      1.7833          2           0.206995      0\n",
        "0  698757980          false      1.5982          2           0.185509      0\n",
        "\n",
        "Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with [[PTCL]] received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, [[vincristine]] and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757981\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757981       positive      4.3905          5           0.498835      1\n",
        "0  698757981          false      3.6610          4           0.415952      0\n",
        "1  698757981       negative      0.7500          1           0.085213      0\n",
        "\n",
        "[[Intra-articular injection of lidocaine]] before closed reduction of [[anterior shoulder dislocation]] produces the same pain relief as intravenous meperidine and diazepam.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757982\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757982       positive       9.105         10                  1      1\n",
        "\n",
        "Administration of full-dose R-CHOP (rituximab/[[cyclophosphamide]]/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or [[high-grade non-Hodgkin lymphoma]] but might be difficult in older patients.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757983\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757983       positive      8.6152         10                  1      1\n",
        "\n",
        "[[5-aminosalicylic acid]] inhibits [[colitis-associated colorectal dysplasias]] in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757984\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757984    speculative      4.4782          5           0.519802      0\n",
        "1  698757984       positive      2.5013          3           0.290336      1\n",
        "0  698757984          false      1.6357          2           0.189862      0"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "Selective cytotoxicity of [[indomethacin]] and [[indomethacin]] ethyl ester-loaded nanocapsules against [[glioma]] cell lines: an in vitro study.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757985\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757985       positive      8.7571         10                  1      1\n",
        "\n",
        "The main finding of the present study is that [[indomethacin-loaded nanocapsules]] formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of [[glioma]] lines.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757986\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757986       positive      3.5699          4           0.404274      1\n",
        "0  698757986          false      3.4819          4           0.394308      0\n",
        "3  698757986    speculative      0.9286          1           0.105159      0\n",
        "1  698757986       negative      0.8500          1           0.096258      0\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and [[aspergillosis]] (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757987\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757987       positive      6.3978          7           0.718555      1\n",
        "0  698757987          false      0.9286          1           0.104294      0\n",
        "3  698757987    speculative      0.8500          1           0.095466      0\n",
        "1  698757987       negative      0.7273          1           0.081685      0\n",
        "\n",
        "Incidence of melanoma and other malignancies among [[rheumatoid arthritis]] patients treated with [[methotrexate]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757988\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757988       positive      3.5266          4           0.409346      1\n",
        "2  698757988    speculative      2.6404          3           0.306482      0\n",
        "0  698757988          false      2.4482          3           0.284172      0\n",
        "\n",
        "To determine cancer risk in a cohort of 459 [[rheumatoid arthritis]] (RA) patients treated with [[methotrexate]] in community practice.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757989\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757989    speculative      5.9840          7           0.683331      0\n",
        "1  698757989       positive      1.9231          2           0.219605      1\n",
        "0  698757989          false      0.8500          1           0.097064      0\n",
        "\n",
        "The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and [[indomethacin ethyl ester-loaded nanocapsules]] on [[glioma]] cell lines.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757990\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757990       positive      8.9037         10                  1      1\n",
        "\n",
        "Compared with the general population, [[methotrexate]]-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and [[lung cancer]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757991\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698757991       positive      4.5302          5           0.497551      0\n",
        "0  698757991          false      2.7248          3           0.299264      1\n",
        "1  698757991       negative      1.8500          2           0.203185      0\n",
        "\n",
        "Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral [[anticoagulant]] and instituting heparin therapy prior to the planned dental procedure, which can result in [[thromboembolism]] and increased morbidity and mortality.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757992\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757992       positive      4.3875          5           0.511340      1\n",
        "0  698757992          false      3.4429          4           0.401252      0\n",
        "2  698757992    speculative      0.7500          1           0.087409      0\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced [[gingival overgrowth]] (P <0.001) than in patients with periodontitis and the controls.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757993\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757993       positive      8.7659         10                  1      1\n",
        "\n",
        "Finally, in non-small cell [[lung cancer]] (NSCLC) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for [[lung cancer]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757994\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757994       positive      8.7659         10                  1      1\n",
        "\n",
        "Finally, in non-small cell lung cancer ([[NSCLC]]) in patients' progressing on chemotherapy [[sutent]] was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757996\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757996       positive      7.8056          9           0.899201      1\n",
        "1  698757996    speculative      0.8750          1           0.100799      0\n",
        "\n",
        "During the induction phase, tacrolimus or cyclosporine, [[mycophenolate mofetil]], and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757997\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698757997       positive      7.9842          9           0.904172      1\n",
        "0  698757997       negative      0.8462          1           0.095828      0\n",
        "\n",
        "During the induction phase, [[tacrolimus]] or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757998\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757998       positive      8.5317         10                  1      1\n",
        "\n",
        "During the induction phase, tacrolimus or [[cyclosporine]], mycophenolate mofetil, and methylprednisolone were used for [[immunosuppression]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698757999\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698757999       positive      6.0583          7            0.69971      1\n",
        "1  698757999    speculative      2.6000          3            0.30029      0"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "[[Zidovudine]] discontinuation could help to avoid [[anaemia]] associated with anti-HCV therapy.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758000\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758000       positive      4.9197          6           0.590168      1\n",
        "0  698758000       negative      3.4164          4           0.409832      0\n",
        "\n",
        "There is evidence in the literature that inhaled corticosteroids ([[ICSs]]) are safe for pregnant women with [[asthma]] and their infants.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758002\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758002       positive      8.9037         10                  1      1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, [[headache]] intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and [[headache]] duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758003\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758003       positive      8.6583         10                  1      1\n",
        "\n",
        "Results - The [[topiramate]] group showed a reduction in the mean (+/-SD) of monthly [[migraine]] frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758004\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758004       positive      8.6806         10                  1      1\n",
        "\n",
        "Long-term exposure to [[medium-dose glucocorticoid]] therapy associates with [[hypertension]] in patients with rheumatoid arthritis.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758005\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758005       positive      6.1295          7           0.711475      1\n",
        "2  698758005    speculative      1.6357          2           0.189862      0\n",
        "0  698758005          false      0.8500          1           0.098663      0\n",
        "\n",
        "[[Pulmonary alveolar proteinosis]]: a rare pulmonary toxicity of [[sirolimus]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758006\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758006       negative      4.3890          5           0.498665      0\n",
        "2  698758006       positive      3.5625          4           0.404761      0\n",
        "0  698758006          false      0.8500          1           0.096574      1\n",
        "\n",
        "Compared with both diuretics and contemporary agents, [[amlodipine]] decreases cardiovascular events to a similar or greater extent without evidence for increased [[coronary heart disease]], gastrointestinal bleeding or cancer.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758008\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758008       positive      6.6679          8           0.799882      0\n",
        "0  698758008       negative      0.8500          1           0.101966      0\n",
        "2  698758008    speculative      0.8182          1           0.098151      0\n",
        "\n",
        "The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium ([[DSS]])-induced [[colitis-associated neoplasia]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758009\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758009       positive      9.2635         11           0.912444      1\n",
        "1  698758009    speculative      0.8889          1           0.087556      0\n",
        "\n",
        "[[Cocaine]] abuse is associated with [[cerebrovascular events]]; spinal cord effects are rarely reported.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758010\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758010       positive      6.1282          7           0.696268      0\n",
        "1  698758010    speculative      2.6733          3           0.303732      0\n",
        "\n",
        "Recently, there have been reports of [[noninfectious granulomatous syndromes]] in patients receiving [[etanercept]] for a variety of diseases.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758011\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758011       positive       8.105          9            0.89017      0\n",
        "1  698758011    speculative       1.000          1            0.10983      0\n",
        "\n",
        "Past use of antimetabolites, T-cell inhibitors, [[alkylating agents]], and other immunosuppressives is ascertained from medical records of approximately 9,250 [[ocular inflammation]] patients at five tertiary centers over up to 30 years.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758012\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758012       positive      8.7571         10                  1      1\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with [[febuxostat]] than with allopurinol.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758013\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758013       positive       9.105         10                  1      1\n",
        "\n",
        "[[BiRD]] is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed [[multiple myeloma]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758014\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758014          false      4.2872          5           0.514293      0\n",
        "1  698758014       negative      2.3864          3           0.286273      0\n",
        "2  698758014       positive      0.8500          1           0.101966      1\n",
        "3  698758014    speculative      0.8125          1           0.097468      0\n",
        "\n",
        "Data of our study revealed an unexpected high rate of hypogonadism irrespective of [[cyclophosphamide]] use, and subclinical involvement of the testes by the [[vasculitis]] itself might be an alternative explanation.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758015\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758015       positive      8.7619         10                  1      1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, vomiting, and [[diarrhea]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758016\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758016       positive      8.6583         10                  1      1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "[[PAP]] is a very rare complication of [[SRL]] therapy with only a few cases described.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758017\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758017       positive      6.9068          8            0.78473      0\n",
        "1  698758017    speculative      1.8947          2            0.21527      0\n",
        "\n",
        "Two years after initiating [[SRL]], she presented complaints of progressive dyspnoea, [[nonproductive cough]], chest pain and low-grade fever of 1 month duration.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758018\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758018       positive      6.0585          7           0.710116      1\n",
        "0  698758018          false      2.4732          3           0.289884      0\n",
        "\n",
        "Similarly, the same regimen of posaconazole reduced [[invasive fungal infections]] (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and [[itraconazole]] in neutropenic patients.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758020\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758020       positive      4.5643          5           0.501296      0\n",
        "1  698758020    speculative      4.5407          5           0.498704      1\n",
        "\n",
        "At this time, [[posaconazole]] should probably be reserved for prophylaxis in patients at high risk for invasive fungal infection, as salvage therapy in refractory or [[resistant infections]], or for patients with intolerance to other therapies.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758022\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758022       positive      8.6806         10                  1      1\n",
        "\n",
        "[[Posaconazole]], in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758023\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698758023       positive      6.6997          8           0.803697      1\n",
        "0  698758023          false      0.8182          1           0.098151      0\n",
        "1  698758023       negative      0.8182          1           0.098151      0\n",
        "\n",
        "Oral BDP prevents [[relapses of gastrointestinal GVHD]] following tapering of [[prednisone]]; survival is statistically significantly better among patients receiving BDP.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758024\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758024       positive      5.4381          6           0.620993      1\n",
        "0  698758024          false      2.4857          3           0.283850      0\n",
        "2  698758024    speculative      0.8333          1           0.095157      0\n",
        "\n",
        "Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough [[invasive fungal infections]] (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving [[fluconazole]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758025\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758025       positive      7.7833          9           0.898941      1\n",
        "0  698758025          false      0.8750          1           0.101059      0\n",
        "\n",
        "The primary reasons for withdrawal were similar across groups except for [[gout flares]], which were more frequent with febuxostat than with [[allopurinol]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758026\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758026    speculative      4.5405          5            0.51821      0\n",
        "0  698758026       positive      4.2214          5            0.48179      0\n",
        "\n",
        "Exposure to [[Benzodiazepines]] (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, [[orofacial clefts]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758027\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698758027       positive      5.9119          7           0.674728      0\n",
        "1  698758027    speculative      2.8500          3           0.325272      0\n",
        "\n",
        "Maternal use of [[BZD]] and/or HBRA may increase the risk for [[preterm birth]] and low birth weight and cause neonatal symptoms, but does not appear to have a strong teratogenic potential.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698758028\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698758028    speculative      5.3191          6            0.60434      0\n",
        "0  698758028       positive      3.4824          4            0.39566      0\n",
        "\n",
        "Exposure to Benzodiazepines ([[BZD]]) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, [[orofacial clefts]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698936313\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698936313       positive      8.0537          9           0.904534      1\n",
        "0  698936313          false      0.8500          1           0.095466      0\n",
        "\n",
        "[[Cocaine]] abuse is associated with [[cerebrovascular events]]; spinal cord effects are rarely reported.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698936583\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698936583       positive      8.9037         10                  1      1\n",
        "\n",
        "All three patients had recurrent admissions for stomal bleeding and [[stomal varices secondary to portal hypertension]] and were initially treated with local measures (pressure, [[silver nitrate]], and suture ligation).\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698936792\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698936792       positive      7.7571          9           0.885807      1\n",
        "1  698936792    speculative      1.0000          1           0.114193      0\n",
        "\n",
        "This study demonstrated that both low-dose [[topiramate]] and propranolol could significantly reduce [[migraine headache]] frequency, intensity, and duration.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698937471\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698937471       positive      8.6583         10                  1      1"
       ]
      },
      {
       "output_type": "stream",
       "stream": "stdout",
       "text": [
        "\n",
        "\n",
        "For exposure levels within standard recommended guidelines, [[radioisotopes]] are far more likely to play a role in the occurrence of [[spontaneous abortions]] than X-rays.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698937671\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698937671       positive      8.7659         10                  1      1\n",
        "\n",
        "The most common adverse effects associated with the use of [[posaconazole]] include headache, fever, nausea, [[vomiting]], and diarrhea.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698937904\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698937904          false      8.7619         10                  1      1\n",
        "\n",
        "ET-1 mRNA expression was significantly higher in patients with [[CsA]]-induced gingival overgrowth (P <0.001) than in patients with [[periodontitis]] and the controls.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698939052\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698939052          false      6.6736          8           0.800566      1\n",
        "1  698939052       negative      1.6625          2           0.199434      0\n",
        "\n",
        "The frequency of PONV did not correlate to the amounts of [[alfentanil]], propofol, postoperative antiemetics consumed, or to female gender, non-smoking status, and history of PONV or [[motion sickness]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698939741\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "1  698939741    speculative      6.9804          8           0.813529      1\n",
        "0  698939741          false      1.6000          2           0.186471      0\n",
        "\n",
        "Information from the SITE Cohort Study should clarify whether use of these [[immunosuppressive drugs]] for ocular inflammation increases the risk of mortality and [[fatal cancer]].\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698942095\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "0  698942095       negative      8.5804         10                  1      1\n",
        "\n",
        "We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of [[vascular lesions]] during the two years an [[etonogestrel]] implant was used by diabetic women.\n",
        "\n",
        "------------------------------------------------------------\n",
        "unit id: 698942663\n",
        "     unit_id broad_rel_type  conf_score  num_votes  percent_agreement  match\n",
        "2  698942663    speculative      7.0806          8           0.815681      1\n",
        "1  698942663       positive      0.8500          1           0.097919      0\n",
        "0  698942663          false      0.7500          1           0.086400      0\n",
        "\n",
        "We tested the hypothesis that [[oral beclomethasone dipropionate]] (BDP) would control gastrointestinal graft-versus-host disease ([[GVHD]]) in patients with anorexia, vomiting, and diarrhea.\n",
        "\n",
        "------------------------------------------------------------\n"
       ]
      }
     ],
     "prompt_number": 8
    },
    {
     "cell_type": "code",
     "collapsed": false,
     "input": [],
     "language": "python",
     "metadata": {},
     "outputs": []
    }
   ],
   "metadata": {}
  }
 ]
}